SCHEMBL7907765

SCHEMBL7907765

COC(=O)c1ccc(C(=O)c2cccc(O)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.58
CA1 P00915 4/20 0.58
CA2 P00918 4/20 0.58
CA9 Q16790 4/20 0.58
CA7 P43166 3/20 0.58
CA14 Q9ULX7 3/20 0.58
CLK1 P49759 1/20 0.57
DYRK1A Q13627 1/20 0.57
DYRK1B Q9Y463 1/20 0.57
HSD17B1 P14061 5/20 0.55
HSD17B2 P37059 5/20 0.55
P4HB P07237 2/20 0.55
TSHR P16473 1/20 0.55
FASN P49327 1/20 0.54
STS P08842 1/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10420733 0.91 P4HB (0.60) CA12CA1CA2CA9CA7
SCHEMBL2339850 0.87 TSHR (0.61) CA12CA1CA2CA9CA7
Methyl 3-Hydroxybenzoate SCHEMBL29410714 0.87 P4HB (0.67) CA12CA1CA2CA9CA7
Methyl 3-Hydroxybenzoate SCHEMBL67203 0.87 P4HB (0.67) CA12CA1CA2CA9CA7
SCHEMBL9828457 0.86 CA12 (0.63) CA12CA1CA2CA9CA7
Methyl 3-Hydroxybenzoate SCHEMBL29071792 0.85 P4HB (0.65) CA12CA1CA2CA9CA7
SCHEMBL7906383 0.83 CA1 (0.55) CA12CA1CA2CA9CA7
SCHEMBL1772864 0.83 TDP1 (0.58) CA12CA1CA2CA9CA7
SCHEMBL9339134 0.83 CLK1 (0.62) CLK1DYRK1ADYRK1BHSD17B1HSD17B2
SCHEMBL7908137 0.81 PBRM1 (0.66) CA12CA1CA2CA9CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083888-A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS Advanced Medicine, Inc. (US) 2001-03-21 EP disclosed
WO-1999063983-A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS ADVANCED MEDICINE INC (US) 2000-03-23 WO disclosed
WO-1999063983-A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed
US-4920133-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed